Deep Brain Stimulation Systems (DBS)
DeviceSubjects receiving DBS implant for treatment of Essential Tremor
NCT Number: NCT04032470
To compile characteristics of real-world outcomes for Boston Scientific Corporation's commercially approved Deep Brain Stimulation (DBS) Systems, when used according to the applicable Directions for Use, for the treatment of Essential Tremor.
Interested in participating?
Request Info18 year and older
All sexes
Observational
A.o. LKH Univ.-Kliniken Innsbruck, Innsbruck, Austria
To compile characteristics of real-world outcomes using Deep Brain Stimulation (DBS) for the treatment of Essential Tremor to add to the evidence available for treatment of ET.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subjects receiving DBS implant for treatment of Essential Tremor
Time frame: Up to 3 years
Change in quality of life over the course of the study using QUEST
Time frame: Up to 3 years
Improvement in tremor scores as assessed by Fahn-Tolosa-Marin Tremor Rating Scale (FTMTRS) during the study as compared with baseline
Time frame: Up to 3 years
Impression of Change scores during the study using Global Impression of Change
Contact information is provided by the study sponsor or research team.
Diane Keesey
CONTACT
Stephanie Delvaux
CONTACT
Boston Scientific Corporation
Industry
Boston Scientific Registry of Deep Brain Stimulations for Treatment of Essential Tremor (ET):ET Registry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06635811
Central Nervous System Diseases, Essential Tremor
Gainesville, Florida, United States
View Trial DetailsNCT04957095
Basal Ganglia Diseases, Brain Diseases
Dallas, Texas, United States
View Trial DetailsNCT01581580
Basal Ganglia Diseases, Brain Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT06974916
Central Nervous System Diseases, Essential Tremor
Turku, Finland
View Trial Details